Neuroimaging the genetic effects of brain-derived neurotrophic factor on human hippocampus by Egan, Michael F.
136
Poster
Neuroimaging the genetic effects of 
brain-derived neurotrophic factor on 
human hippocampus
Because genes exert their effects on complex phenotypes,
such as mental illness,through intermediary molecular
and physiological mechanisms,these “intermediate phe-
notypes”should have a simpler genetic architecture.This
should make it easier to detect the effects of specific
genetic variants.Intermediate phenotypes referable to
hippocampus have received attention because of its role
in neuropsychiatric disorders such as schizophrenia.
Promising intermediate phenotypes have included mea-
sures of episodic memory, hippocampal activation
assayed with functional magnetic resonace imaging
(fMRI), and hippocampal volume assayed with MRI,
among others. In addition to these relatively complex
intermediate phenotypes,each gene also has related phe-
notypic measures based on its function.For example,the
dopamine D2 receptor exerts its effects by modulating
intracellular cyclic adenosine monophosphate (cAMP)
levels and therefore one can study the functional effects
of mutations in the D2 gene by examining downstream
effects on cAMP levels. Thus, the impact of a specific
genetic variant in a gene can be studied at basic cellular
level,as well as at the systems level.
BDNF is an obvious candidate gene for hippocampal
function in humans because studies in animals have
shown BDNF to be a critical mediator of episodic mem-
ory. For example, BDNF plays an essential role in the
molecular mechanisms of both early and late phases of
long-term potentiation (LTP) through both presynaptic
and postsynaptic mechanisms. To exert these effects,
BDNF is packaged and transported to dendrites,where
it is released and acts as a retrograde messenger.Despite
this work in nonhumans, it has been unclear what role
BDNF played in the greatly expanded,verbally mediated
episodic memory in humans.
The BDNF gene is 66.8 kilobases,has 9 exons,and pro-
duces at least 6 splice variants.All 5´ exons are spliced
out and only the final 3´ exon is translated into protein.
Translation produces a precursor protein,which is pack-
aged into secretory vesicles and eventually cleaved at
amino acid 128 to form the mature BDNF protein.The
BDNF gene was recently found to contain at least one
common polymorphism that changes amino acid
sequence.This is the val66met polymorphism at codon
66,which creates a valine to methionine substitution in
the preprotein.Other missense single nucleotide poly-
morphisms (SNPs) have been described,but appear to
be uncommon.Because val66met is only in the prepro-
tein,it has no effect on the structure or in vitro activity
of the mature BDNF protein.
The relevance of this polymorphism for humans was first
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The genetic determinants of human brain function have long been elusive, but are now begin-
ning to emerge.The conjunction of the sequencing of the human genome (ie, the discovery of all
genes) with the development of new neuroimaging techniques has produced an astonishing leap
forward in our ability to detect the effects of genes on neurobiological processes.This poster
focuses on a prototypical study of the gene for brain-derived neurotrophic factor (BDNF),
showing its role in human hippocampal function and memory.examined in a study of intermediate phenotypes related
to schizophrenia.In a group of 641 subjects,those with a
val allele were found to have significantly better scores
on a test of episodic memory, compared with subjects
homozygous for the met allele.
1This study then showed
that the met allele altered the intracellular trafficking and
release of BDNF.In cultured rodent hippocampal neu-
rons,the val form of the preprotein was packaged into
secretory vesicles and released from dendrites.In con-
trast,the met allele was not well packaged into vesicles,
but instead formed clumps around the nucleus.
Stimulated release in met-containing neurons was
markedly reduced.These experiments suggested that the
met allele exerts its deleterious effects on episodic mem-
ory,because it is not released properly in the hippocam-
pus during formation of episodic memories.
The effects of the val66met polymorphism on episodic
memory scores were weak and by themselves initially not
convincing. However, results from additional imaging
studies offered a remarkable degree of convergent evi-
dence.First,magnetic resonance spectroscopy was used
to assay N-acetylaspartate (NAA), an intraneuronal
metabolite closely correlated with tissue glutamate lev-
els. Reduced NAA levels have been reported in many
neuropsychiatric disorders, including schizophrenia.
NAA is an indirect measure of synaptic abundance
and/or glutamate neurotransmission.In a cohort of 300
subjects,those with a met allele had reduced NAA com-
pared with val/val subjects,consistent with the memory
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Figure 1. Effect of brain-derived neurotrophic factor (BDNF) val66met on
hippocampal activation during an encoding task. Statistical maps
showing where val/val subjects have greater activation compared
with subjects with 1 or 2 met alleles during an incidental encod-
ing task. The highlighted areas are statistical results overlaid onto
averaged structural magnetic resonance images. A. Regions in
right hippocampus and parahippocampal gyrus where val/val sub-
jects show greater activation compared with met subjects during
the initial presentation of a picture, when subjects encode a mem-
ory trace. B. Regions in left and right parahippocampal gyrus
where val/val subjects show greater activation compared with sub-
jects with a met allele during the second presentation of a picture,
when subjects have to retrieve a memory trace. 
Reproduced from reference 2: Hariri AR, Goldberg TE, Mattay VS, et al.
Brain-derived neurotrophic factor val66met polymorphism affects human
memory-related hippocampal activity and predicts memory performance. J
Neurosci. 2003;23:6690-6694. Copyright © 2003. Society for Neuroscience.
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Figure 2. Effect of brain-derived neurotrophic factor (BDNF) val66met on
hippocampal volume. Statistical maps of t-transformed hip-
pocampal volume differences between val/val subjects and those
with a met allele. Subjects with a met allele have reduced volumes
bilaterally in the highlighted areas compared with val/val subjects.
Reproduced from reference 3: Pezawas L, Verchinshi BA, Mattay VS, et al.
The brain-derived neurotrophic factor val66met polymorphism and variants
in human cortical morphology. J Neurosci. 2004;24:10099-10102.
Copyright © 2004. Society for Neuroscience.
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1This suggests that deficient impulse-dependent
BDNF secretion might produce a long-lasting reduction
in dendritic or neuronal density.Second,fMRI was used
to assay hippocampal BOLD (blood oxygenation
level–dependent) signals during an episodic memory
task. Fourteen val/val subjects were compared with 14
subjects with a met allele (val/met and met/met groups
were combined because the latter are rare).
2 Consistent
with the cognitive and NAA findings, the met allele
group showed reduced hippocampal activation during
encoding and retrieval (Figure 1).Greater hippocampal
activation had previously been shown to correlate with
better memory.Thus,the val allele’s ability to be secreted
by dendrites appeared to produce downstream effects on
hippocampal blood flow during encoding of memories
and this was detectable in sample of only 28 subjects.
Similar effects were seen in two other imaging studies.A
second fMRI study used a working memory task where
hippocampal deactivation is typically correlated with
superior performance.In two separate cohorts of 13 and
17 subjects,respectively,subjects with a met allele demon-
strated the deleterious pattern of failure to deactivate
hippocampus.
1 Next, a semiautomated morphometric
technique was used to evaluate BDNF’s effects on actual
hippocampal volume.
3 Pezawas et al
3 found that 42 met
carriers had a 12% to 15% reduction in hippocampal vol-
ume compared with 69 val/val subjects  (Figure 2).
Reduced volume is consistent with reduced NAA,again
suggesting that the met allele’s reduced impulse-depen-
dent release impacted dendritic or neuronal density.In
all,these four neuroimaging studies are remarkable for
both their consistency in showing deleterious effects of
the met allele and because these effects were detected
using such modest sample sizes.
While neuroimaging studies offer convergent evidence
that the BNDF val66met polymorphism affects hip-
pocampal function,it remains unclear what role this SNP
plays in psychiatric disorders. BDNF has been weakly
associated with several psychiatric disorders,including
schizophrenia,mood,and anxiety disorders.Surprisingly,
the val allele is often associated with illness.
4Whether the
causative variant is val66met or a nearby variant in link-
age disequilibrium,other steps in the causal chain remain
to be elucidated. Nevertheless, the discovery that
val66met itself alters intracellular processing and release
of BDNF,and is associated with hippocampal physiolog-
ical responses,in vivo NAA levels,hippocampal size,and
hippocampal-mediated cognition,increases the a priori
likelihood that it plays a role in disorders related to hip-
pocampal function.
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More broadly, these data demonstrate that intermediate phenotypes, particularly neuroimaging
phenotypes, can play a substantial role in elucidating the mechanisms by which specific genetic
variants impact human brain function and risk for common neuropsychiatric disorders.
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